Immanuel Kant argued that human beings must always be treated as ends in themselves, never merely as a means to an end, emphasizing the sanctity of individual autonomy and dignity. The District Magistrate (DM) faces a conflict between the Teleological urge to save a dying tribe and the Deontological duty to follow safety protocols.

Perspective of Medical Ethics

• Non-Maleficence: The core principle of Primum non nocere (first, do no harm) prohibits using untested supplements that may have side effects, potentially worsening the deformity.

• Informed Consent: As per ICMR National Ethical Guidelines (2017) and the 2025 Addendum, research on vulnerable groups requires clear, local-language communication, which is difficult with an isolated tribe.

• Scientific Validity: Bypassing clinical trials violates the Declaration of Helsinki, which mandates that medical research must follow strict experimental protocols before human application.

• Vulnerability Principle: Endangered tribes lack the bargaining power or technical knowledge to challenge university findings, making them susceptible to Medical Paternalism.

• Therapeutic Misconception: The tribe might mistake a research trial for a proven cure, leading to false hope and erosion of trust in formal medicine.

Perspective of Administrative Ethics

• Rule of Law: A DM must act within the Drugs and Cosmetics Act, 1940, which mandates clinical trial approvals from the DCGI; bypassing this is administrative overreach.

• Public Trust: Unverified interventions that fail can lead to permanent alienation of the tribe from state authorities, hindering future programs like PM-JANMAN.

• Objectivity: The DM must remain neutral and not be swayed by unvalidated university claims without a Peer Review or technical validation from the Ministry of Health.

• Accountability: Implementing untested research creates a liability risk for the state if the supplement leads to fatalities, violating Article 21 (Right to Life).

• Fiduciary Duty: As the custodian of tribal welfare, the DM’s role is to ensure safe interventions, not to treat the community as a laboratory for academic hypotheses.

Comparative Ethical Analysis

Way Forward

The DM should adopt a Pragmatic Ethic by facilitating immediate palliative care through Mobile Medical Units under the Dharti Aaba Janjatiya Gram Utkarsh Abhiyan (2026). Simultaneously, the DM must expedite formal trials via the Bharat Tribal Health Observatory (2026) and ICMR-RMRC to validate the supplement safely.

The DM must balance Compassion with Rationality, ensuring that the survival of a tribe is achieved through Ethical Governance and scientific integrity rather than administrative expediency.